<?xml version="1.0" encoding="UTF-8"?><!-- Converted from Majour with majour2a++ V1.5 --><!--Automatically converted from version 2.3 to 2.4-->

<!DOCTYPE Publisher
  PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>

   <PublisherInfo>

      <PublisherName>Springer-Verlag</PublisherName>

      <PublisherLocation>Berlin/Heidelberg</PublisherLocation>

   </PublisherInfo>

   <Journal>

      <JournalInfo JournalProductType="Legacy" NumberingStyle="Unnumbered">

         <JournalID>105</JournalID>

         <JournalPrintISSN>0017-8470</JournalPrintISSN>

         <JournalSPIN/>

         <JournalTitle>Der Hautarzt</JournalTitle>

         <JournalSubTitle>Zeitschrift für Dermatologie, Allergologie, Venerologie und verwandte Gebiete</JournalSubTitle>

         <JournalAbbreviatedTitle>Hautarzt</JournalAbbreviatedTitle>
         <JournalSubjectGroup>
            <JournalSubject Type="Primary">Legacy</JournalSubject>
         </JournalSubjectGroup>

      </JournalInfo>

      <Volume>

         <VolumeInfo VolumeType="Regular">
            <VolumeIDStart>46</VolumeIDStart>
            <VolumeIDEnd>46</VolumeIDEnd>
            <VolumeIssueCount/>
         </VolumeInfo>

         <Issue IssueType="Regular">

            <IssueInfo TocLevels="0">

               <IssueIDStart>9</IssueIDStart>

               <IssueIDEnd>9</IssueIDEnd>

               <IssueHistory>

                  <PrintDate>

                     <Year>1995</Year>

                     <Month>9</Month>

                     <Day>15</Day>

                  </PrintDate>

                  <CoverDate>

                     <Year>1995</Year>

                     <Month>9</Month>

                  </CoverDate>

               </IssueHistory>

               <IssueCopyright>

                  <CopyrightHolderName>Springer-Verlag Berlin Heidelberg</CopyrightHolderName>

                  <CopyrightYear>1995</CopyrightYear>

               </IssueCopyright>

            </IssueInfo>

            <Article ID="Art1">

               <ArticleInfo Language="De" ArticleType="OriginalPaper" NumberingStyle="Unnumbered" ContainsESM="No" TocLevels="0">

                  <ArticleID>50460603.105</ArticleID>

                  <ArticleDOI>10.1007/s001050050305</ArticleDOI>

                  <ArticleTitle Language="De">Mutationen der G Proteine</ArticleTitle>

                  <ArticleSubTitle Language="De"/>

                  <ArticleCategory>AKTUELLER KOMMENTAR</ArticleCategory>

                  <ArticleFirstPage>603</ArticleFirstPage>

                  <ArticleLastPage>606</ArticleLastPage>

                  <ArticleCopyright>

                     <CopyrightHolderName>Springer-Verlag Berlin Heidelberg</CopyrightHolderName>

                     <CopyrightYear>1995</CopyrightYear>

                  </ArticleCopyright>
                  <ArticleGrants>
                     <MetadataGrant Grant="OpenAccess"/>
                     <AbstractGrant Grant="OpenAccess"/>
                     <BodyPDFGrant Grant="Restricted"/>
                     <BodyHTMLGrant Grant="Restricted"/>
                     <BibliographyGrant Grant="Restricted"/>
                     <ESMGrant Grant="Restricted"/>
                  </ArticleGrants>

               </ArticleInfo>

               <ArticleHeader>

                  <AuthorGroup>

                     <Author AffiliationIDS="A1">

                        <AuthorName DisplayOrder="Western">

                           <GivenName>Ralph M.</GivenName>

                           <FamilyName>Trüeb</FamilyName>

                        </AuthorName>

                     </Author>

                     <Affiliation ID="A1">

                        <OrgName>Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas, USA</OrgName>

                        <OrgAddress>

                           <Street/>

                           <Postbox/>

                           <Postcode/>

                           <City/>

                           <State/>

                           <Country>US</Country>

                        </OrgAddress>

                     </Affiliation>

                  </AuthorGroup>

                  <Abstract ID="Abs1" Language="De">

                     <Heading>Zusammenfassung</Heading>

                     <Para/>

                     <Para>

                        <Emphasis Type="Italic">Guanosinphosphat-bindende Proteine (G-Proteine) übermitteln Information vom Zelläußeren ins Zellinnere, indem sie Rezeptormoleküle der Zelloberfläche mit Effektormolekülen an der Innenseite der Membran koppeln. Zahlreiche Rezeptoren leiten sehr unterschiedliche Signale über eine Reihe G-Proteine zu einer kleinen Zahl sekundärer Botensysteme im Zellinnern. Die G-Proteine stellen ein molekulares Schaltsystem dar, das ein- und ausgeschaltet werden kann. Der sog. α-Untereinheit der G-Proteine (Gα) kommt eine entscheidende Rolle in der Regulation der Effektoren zu. Gα-Mutationen können zu einer dauernden Signalverstärkung oder zum Verlust der Signalübertragung führen. Aufgrund der zahlreichen Funktionen, denen dieses Prinzip der G-Protein-gekoppelten Signalübertragung dient, überrascht nicht, daß Anomalien der G-Proteine oder ihrer gekoppelten Rezeptoren zu sehr unterschiedlichen Krankheitsmanifestationen führen können. Darüber hinaus wird bei einem gegebenen Defekt der G-Protein-vermittelten Signalübertragung das Ausmaß des Krankheitsphänotyps von der Ubiquität der gestörten Komponente abhängen: Defekte hochspezialisierter, G-Protein-gekoppelter Rezeptoren führen zu fokalen Störungen, während Defekte ubiquitärer G-Proteine zu generalisierten Störungen (Bsp. Albright's hereditäre Osteodystrophie) Anlaß geben. Somatische Mutationen auch ubiquitärer G-Proteine können allerdings entsprechend der Gewebsverteilung der Mutation (Mosaizismus) ebenfalls zu fokalen Anomalien führen (Bsp. McCune-Albright-Syndrom).</Emphasis>

                     </Para>

                  </Abstract>

                  <Abstract ID="Abs2" Language="En">

                     <Heading>Summary</Heading>

                     <Para/>

                     <Para>Guanine nucleotide-binding proteins (G proteins) function as transducers of information across the cell membrane by coupling receptors to effectors. A large number of G protein-linked receptors funnel extra-cellular signals as diverse as hormones, growth factors, neurotransmitters, and primary sensory stimuli through a set of G proteins to a small number of second-messenger systems. The G proteins act as molecular switches with an „on“ and „off“ state governed by a GTPase cycle. By virtue of its high affinity and specificity for guanine nucleotide binding and its intrinsic GTPase activity, the α-subunit of the G protein (Gα) plays the critical role in regulation of the effectors by their corresponding G protein. Mutations of Gα may result in either constitutive activation or loss of expression mutations. Given the variety of functions subserved by G protein-coupled signal transduction, it is not surprising that abnormalities in G protein-coupled pathways can lead to diseases with manifestations as dissimilar as blindness, hormone resistance, precocious puberty and neoplasia. For a given defect in a G protein-coupled pathway, the extent of the manifestations will also be determined by the cellular distribution of the affected component. Defects in components expressed exclusively in a single cell type will cause more a focal disorder than defects in a widely expressed component, particularly in germline mutations (e.g., Albright's hereditary osteodystrophy), whereas somatic mutations of genes encoding even an ubiquitously expressed component can cause focal disease when the somatic mutation itself is focal (e.g., McCune-Albright syndrome).</Para>

                  </Abstract>

                  <KeywordGroup Language="De">

                     <Keyword>Schlüsselwörter G-Proteine</Keyword>

                     <Keyword>Gsα-Mutationen</Keyword>

                     <Keyword>Albright's hereditäre Osteodystrophie</Keyword>

                     <Keyword>McCune-Albright-Syndrom</Keyword>

                     <Keyword>Testotoxikose</Keyword>

                  </KeywordGroup>

                  <KeywordGroup Language="En">

                     <Keyword>Key words G proteins</Keyword>

                     <Keyword>Mutations of Gsα</Keyword>

                     <Keyword>Albright's hereditary osteodystrophy</Keyword>

                     <Keyword>McCune Albright syndrome</Keyword>

                     <Keyword>Testotoxicosis</Keyword>

                  </KeywordGroup>

                  <ArticleNote Type="Misc">

                     <SimplePara>Eingegangen am 14. November 1994 Angenommen am 10. April 1995</SimplePara>

                  </ArticleNote>

               </ArticleHeader>

               <NoBody/>

            </Article>

         </Issue>

      </Volume>

   </Journal>

</Publisher>